This experimental study demonstrated that pretreatment with the BRD4 selective inhibitor JQ1 prior to the induction of ischemia might dramatically reduce the level of inflammatory cytokines (TNF) compared to those in the control and vehicle groups. This evidence concerns the gene TNF and ischemia.